Clinical Trials Directory

Trials / Unknown

UnknownNCT00516971

The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Hospital Authority, Hong Kong · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The purpose of this study is to evaluate the efficacy of proton pump inhibitor for the treatment of non-erosive reflux disease (NERD) in Chinese population. Studies from the western population have estimated a worldwide prevalence of gastro-oesophageal reflux disease from 10 to 20 %. Monthly symptoms of heartburn or acid regurgitation were found in 9.3% of subjects according to a population survey in Hong Kong. Most of these patients did not show evidence of erosive change during upper endoscopy. However, patients with NERD suffer from similar impairment of quality of life as patients with erosive oesophagitis and their symptoms are as severe as patients with erosive disease. Data on the use of proton pump inhibitor for the treatment of NERD in Chinese patients are scanty. Thus we want to perform a double-blind randomised placebo-controlled study to evaluate the efficacy of proton pump inhibitor for the treatment of NERD in Chinese population.

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazole 20mg once daily

Timeline

Start date
2003-01-01
Completion
2008-12-01
First posted
2007-08-16
Last updated
2010-07-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00516971. Inclusion in this directory is not an endorsement.

The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Populatio (NCT00516971) · Clinical Trials Directory